WINTER 2016
ACCESS
A PUBLICATION OF COMMUNIT Y RESEARCH INITIATIVE OF NEW ENGL AND
Expanding HDAP’s Programs to Better Serve
Our Community
It may only be the beginning of the year, but CRI’s HIV Drug Assistance
Program (HDAP) team is already planning a busy 2016 with expanded
training and outreach, improved application processes, and exciting new
projects to better serve our community. None of this would be possible
without our ongoing collaborations with consumers, case managers,
donors, insurers, pharmacists, and clinical providers like you.
Building BRIDGEs across Massachusetts
Finding health insurance can be difficult, but the BRIDGE (Benefits
Resources Infectious Disease Guidance and Engagement) team is here
to help. BRIDGE offers assistance and support to clients, providers, and
case managers as they negotiate the complicated public and private
insurance landscape.
The MA HIV Drug Assistance Program is
here to help you!
The BRIDGE team develops unique training sessions to provide critical
information about health insurance options, important factors to
consider for people with HIV when selecting insurance, and strategies to
avoid potential gaps in coverage with less-than-optimum plans. BRIDGE
team members also provide individualized technical assistance to clients
as they select coverage during the open enrollment period and apply
for governmental programs throughout the year. As we begin 2016, the
BRIDGE team is helping HDAP clients reconcile potential tax credits as a
result of their enrollment in subsidized health insurance plans from the
MA state health insurance marketplace under the ACA.
New programs to better serve you
INSIDE ACCESS
HDAP Update p 2
Expanding HDAP’s Programs to
Better Serve Our Community
Research Update p 3
Find Out if You Are Eligible for
New Trials
News and Events p 4-5
You Got Your Wheels Spinning for
Ride 13
Your Critical Support p 6-7
A Special Way to Honor
and Remember
Recognized for our excellence in working with the HIV community, we
are embarking on an exciting pilot project with state-funded tuberculosis
(TB) clinics to increase the use of health insurance to provide needed
medications. The goal of this project is to reduce potential barriers to TB
treatment and explore potential cost savings.
We are also exploring a new program to assist with the cost of medical
co-pays and other out-of-pocket expenses for those HDAP clients most
in need. With this new pilot medical co-pay program, we hope to help
eliminate barriers faced by Massachusetts residents with HIV in accessing
life-saving medications.
Easier to use online application
You talked, and we listened. CRI is finalizing steps to develop a new
electronic HDAP application so program participants can complete and
submit their application online. (Continued on pg 2)
(Continued from pg 1)
Collaborating to improve access, treatment, and prevention
HDAP staff is working with colleagues throughout the state to strategize the best way to ensure access
to HIV and hepatitis C (HCV) treatment and prevention services, including pre-exposure prophylaxis (PrEP)
and recently approved HCV medications. CRI’s clinical research staff members are looking at how CRI can
participate in research, diagnosis, education, and prevention planning to help fight emerging global diseases.
CRI in the Community
From Worcester to the State House, CRI Advocates and Educates
CRI staff members George Hastie, Sasha Samuel, Craig Wells, Lauren Dunn, and Julia Green joined organizations
from across the state at the World AIDS Day event at the State House
BRIDGE team member Lauren Dunn at a training in Cambridge
HDAP Program Manager Nirka Rosa at Boston Health
Care for the Homeless
Rob Quinn joined HDAP BRIDGE Project Manager George
Hastie at Worcester Pride
CRI ACCESS
2
R
C
New Open and Enrolling Trials at CRI
Find Out if You Are Eligible to Participate
CRI is currently enrolling participants in the following clinical trials at our
research facility in Boston. For details about additional ongoing studies, visit
www.crine.org and click the Join a Clinical Trial button at the top of the
homepage. For more information about participating in a clinical trial, call our
research team at 617.502.1707.
o m m u n i t y
e s e a R C h
of
RESEARCH UPDATE
i
n i t i a t i v e
new england
Board of Directors
Scott Sylvia, OD, MBA
President
John W. Devlin, PharmD
Vice President
Jonathan B. Goode
Treasurer
Paul Moreno
Clerk
Alfredo Hernandez Chavez
Ann Webster, PhD
Leadership Council
AMBER
The Amber study is designed for people who are at least 18 years old, HIVpositive, and have never been on treatment.
This study evaluates how safe and effective an investigational single-tablet
regimen is in treating HIV compared to an approved multi-tablet regimen.
Participants are randomized to take either the experimental single-tablet
regimen darunavir / cobicistat / emtricitabine / tenofovir alafenamide (D/C/F/
TAF), or a multi-tablet regimen consisting of darunavir / cobicistat (DRV/COBI)
coadministered with emtricitabine / tenofovir disoproxil fumarate (FTC/TDF).
TAF, a component of the experimental regimen, is an investigational novel
pro-drug of first-line agent tenofovir that has demonstrated high antiviral
efficacy with an improved renal and bone safety profile.
HIV medications, labs, and exams are provided through the study at no cost, for
the duration of 48 weeks with a possible extension. A bone density substudy is
available for participants who sign a separate informed consent. Subjects may
be eligible to receive compensation.
If you are over 18, have been diagnosed with HIV, and have not been on
treatment, you may be eligible to participate! Please contact Joanne Delaney
at [email protected] or 617.502.1707 to find out more.
BIO SAMPLE
CRI is currently seeking participants to donate blood samples for use in the
evaluation of new lab testing methods for syphilis diagnosis. Participants must
be over 18 and have been diagnosed with syphilis one or more times within the
past 10 years. Laboratory test results and / or medical records may be required.
Those co-infected with HIV, hepatitis C, or another STD are eligible.
Eligible volunteers will be asked to provide four tubes of blood and complete
a short questionnaire. Participants will receive a $25 gift card at the end of
the visit.
For more information, please contact the CRI Research Team at 617.502.1707.
New studies are always in development at CRI. For information about
participating, visit www.crine.org or call our research team at 617.502.1700.
Jon Appelbaum, MD
Robert Beck
Donald Butterfield, MD
Ronald Chapman
Mark Christofi
Calvin Cohen, MD, MSc,
Founding Research Director
Carolyn Crowley
Jonathan Crutchley
Glenn Daidone
Victor DePoalo
Richard Dickinson
Douglas Dolezal
Dixie-Lee Esseltine, MD
Kenn Freed, CPA
Jane Garb
Clive Godwin
Joel Goldstein, PhD
Roger Hanzes
Sheila Hussey
Larry Hyer
Lenore Jackson-Pope, RN, ACRN
Bobby Kelley
Ian Lekus, PhD
Tim Martinez, DMD
John Mazzullo, MD
Ellen Morris McCann
Crane McCune
Michael McGuill, DVM, MPH
Jim Morgrage
Frank Ribaudo
Paul Ross, EdD
Harry Schrager, MD
Sandy Sheble-Hall, RN, ACRN
Gregory Welch
Executive Director
Julie K. Marston, MPH
Deputy Executive Director/HDAP
Program Director
Craig R. Wells, MSL
Research Director/Principal Investigator
of Hepatitis C Studies
Amy Colson, MD, MPH
Associate Research Director/Principal
Investigator of HIV Studies
Hannah Bouldin Olivet, MD
Research Operations Director
Julia Green, MS, NP-C, CCRP
You can connect your community to
research, treatment, and education.
Like CRI on Facebook, follow us on
Twitter, and watch our YouTube videos
CRI’s Mission:
To lead the way in clinical HIV/AIDS and
hepatitis C research and to ensure access
to lifesaving drugs and health insurance to
those in need.
Director of Communications
and Development
Michael Corrente, MPA
ACCESS Editor
Marybeth McCabe
CRI ACCESS
3
NEWS AND EVENTS
New HIV & HCV Medication Chart Available
Your Go-To Guide Now Includes Hepatitis C Medications
CRI’s HIV & HCV Medication Chart is here! The medication chart is a complete
two-page reference guide that displays or names all formulations of HIV
and hepatitis C medications currently or recently available as of November
2015. It serves as a powerful educational resource and adherence tool for
providers, case managers, and consumers.
CRI produces the HIV & HCV Medication Chart with partial funding from
the Bureau of Infectious Disease, Office of HIV/AIDS, Massachusetts
Department of Public Health.
You can view the chart online at:
www.crine.org/our-research/hiv-hcv-medication-chart
or request full-color laminated copies by contacting Marybeth McCabe
at 617.502.1726 or [email protected].
Advocating for Care and Coverage in the HIV Community
CRI Supports Bill to Cover Side Effect of HIV Treatment
CRI Executive Director Julie Marston and BRIDGE Project Manager George
Hastie joined HIV activists from several local organizations to testify before
the MA Joint Committee on Financial Services to support a bill that calls for
coverage for lipodystrophy treatment.
Image courtesy of Gay & Lesbian Advocates & Defenders
CRI Executive Director Julie Marston
testifies with AIDS Action Committee
Executive Director Carl Sciortino
While there is simple and effective treatment available for lipodystrophy, it
is not generally covered by insurance companies because it is classified as a
cosmetic procedure. Passage of this bill would ensure that those suffering
from lipodystrophy can access the treatment that they need.
For more information about this bill, visit www.glad.org/tlc.
Victory Programs Honors CRI Executive Director Julie Marston
Celebrating 25+ Years of Commitment to the HIV/AIDS Community
On December 10, Victory Programs presented CRI Executive Director Julie
Marston with the 2015 Peter Medoff Award for her incredible commitment,
dedication, and service to the HIV/AIDS community in Massachusetts.
The Medoff Award is given in honor of Peter Medoff, a founder of AIDS
Housing Corporation and a dedicated community leader who tackled the
issues of poverty, homelessness, and HIV/AIDS.
images courtesy of Nancy Millstrom
Julie has led CRI for over 25 years and previously oversaw the first Public
Health AIDS Program within the Boston Dept. of Health & Hospitals (now
the Boston Public Health Commission). On being honored with the Medoff
Award, Julie says, “I am very proud of what we all have accomplished, and
we are not done. Peter would still be advocating for a cure and for removing
stigma. We must too.”
Congratulations, Julie!
CRI ACCESS
4
(1) CRI Executive Director Julie Marston
speaking at Victory Programs’ Homes
for the Holidays event. (2) Julie Marston
accepting the Peter Medoff Award
from Dr. John Mazzullo (left) and
Victory Programs Executive Director
Jonathan Scott (center)
NEWS AND EVENTS
You Got Your Wheels Spinning for Ride 13
Thank You for Supporting CRI at Harbor to the Bay
On December 2, CRI riders and crew joined members of our staff, CAB, and Board of Directors to celebrate
the amazing dedication that raised over $68k for CRI at this year’s Harbor to the Bay. H2B Board President Jim
Morgrage presented the Ride 13 check to CRI and reminded us all just how important every mile you ride, sign
you wave, hour you volunteer, and dollar you donate to Harbor to the Bay is to making CRI’s HIV/AIDS clinical
research, outreach, and treatment education possible. Thank you for being a part of Ride 13!
Your support for
CRI at H2B funds
research that
changes lives!
Join CRI for Harbor to the Bay Ride 14
on Saturday, September 17, 2016!
More details at www.crine.org/h2b
For the past 14 years, hundreds of people like you have come together to ride, volunteer, and raise money to
support life-saving HIV/AIDs and hepatitis C clinical research by joining CRI at Harbor to the Bay.
You can join this amazing group of people today by registering to ride in Harbor to the Bay 2016 and naming
CRI as your beneficiary! You’re not just pedaling from Boston to Provincetown, you’re pedaling to save lives!
CRI ACCESS
5
n
on
CRI ACCESS
5
YOUR CRITICAL SUPPORT
You Make Lives Better!
Thank you to our leadership donors, who go above and beyond to support research that improves lives around the world.
Below is a list of the leadership donors who contribute to our important efforts.
CRI’s Research Circle honors all
of you who take a leadership role
in supporting CRI with an annual
donation of $5,000 or more:
Dr. Cal Cohen Fund honors all of
you who support CRI’s efforts with
an annual donation of $2,500 or
more:
CRI’s 1500 Fund is the sustaining
gift program for annual donors of
$1,500 or more:
Jay Anderson
5 Star Travel Services
BNY Mellon Community Partnership
Robert R. Beck
American Tower Corporation
Anne Covert
Ronald Chapman & Crane McCune
ARTCO / Jim Viola
Doug Dolezal & Greg Welch
Calvin Cohen, MD, MSc
Donald E. Butterfield, MD
Jonathan Crutchley
Rob Caro
Kia R. Earp
in honor of all those before me
Victor DePoalo
Community Health Charities of New England
John Devlin & Marc Hall
Dickinson Lab / Richard Dickinson
Discovery Communications
Eastern Bank
Kenneth Freed, CPA/Kenneth Freed &
Company/Freed Investment Group LLC
Dixie-Lee Esseltine, MD & Debbie Taylor
in honor of Rick Esseltine & Darla Taylor
Lisbeth & Lyle G. Hall
in honor of Sandy Sheble-Hall
Roger M. Hanzes
Gilead Sciences
Rufus Gifford & Stephen DeVincent/Gifford
Family Foundation of the Bank of
America Charitable Gift Fund
in honor of Cal Cohen, MD, MSc
Edward Moore & Shawn Brooks/Moore
Family Fund, a Fidelity Charitable DonorAdvised Fund
Harbor to the Bay
Marcus Builders LLC
Sean McConnell
Jonathan Goode & Cary Raymond
in honor of Doug Dolezal & Greg Welch
Seth Grosshandler & Kim Wainwright
Danny Hamilton & Paul Hilliard
Ken J. Lima & Mark Sacco
Loretta Moreno
in honor of Paul Moreno & Stephen Barlow
Paul Moreno & Stephen Barlow
Lawrence R. Hyer/Lawrence R. Hyer Fund,
a Fidelity Charitable Donor-Advised Fund
Online Buddies Inc.
Wendy Marston
Myrtle Baptist Church
The Red Inn
Millennium Matching Gift Program
Peter Tenggren
Novartis U.S. Foundation
Michael Stone, DMD
In honor of Ann Webster, PhD
Ann Webster, PhD
Hannah & Jeffrey Olivet
Daniel Sullivan
Victor’s
Scott Popkowski & Joseph Smith/Popkowski
Smith Family Foundation of the Bank of
America Charitable Gift Fund
Donald E. Vaughan & Lee Ridgway
Bryan Rafanelli & Mark Walsh
Gary Reinhardt
Friends of CRI
Jacob Murray, III, DMD
Every effort has been made to ensure
the accuracy of these lists. We apologize
for any errors and ask that you call our
Development Office at 617.502.1726 or
email corrections to [email protected].
Your generous support makes CRI’s life-changing HIV and HCV treatment research possible! The following donors contributed to
our important efforts between September 1, 2015, and December 31, 2015:
Philip Allessio & Guy Matsuda
in memory of Tom Allessio
Martin Almquist
in honor of Dr. Hannah
Bouldin Olivet
Jon Appelbaum, MD
Jana Bacon
Andrew Balder & Cynthia Sommer
Stephen Barlow
Carl Bazil
Leelo Bertram
Sally Bowden/Sally Bowden
Fund, a Vanguard Charitable
donor-advised fund
in honor of Rob Curtis
CRI ACCESS
6
James Bragg & Gail McGuill
Michael Burke
in memory of Nick Houpis
William Callahan, MD
William Cattey
Paula Cohen
in honor of Cal Cohen, MD, MSc
Marianne Colacray
in honor of Alfredo
Hernandez Chavez
Deborah Colson
in honor of Amy Colson, MD
Helen & Earl Colson
in honor of Amy Colson, MD
Anne Covert
Keith Crosby
Lisa Cruz
in honor of CRI & HDAP
James Curtin
Barbara & Vincent Daidone
in memory of all who died
Miguel Delgado
in memory of Robert Colón &
Orlando Falcón
John Devlin, PharmD
Bruce Dezube, MD &
Esther Dezube
David DiRocco
Rosa & Mark Drapkin, MD
John Dreyer
in honor of Cal Cohen, MD, MSc
Michael & Barbara Eisenson/
Eisenson Family Fund at the
Boston Foundation
in honor of Calvin Cohen, MD, MSc
Charles & Nancy Eliot
in memory of David Eliot
Ruth Eliot
in memory of David Eliot
Joan Epstein & Burt Franzman
Dixie-Lee Esseltine, MD & Deb Taylor
in memory of Phil & Jane Esseltine
Abby Flam
Andrew Fullem
re
gize
ur
or
org.
o
YOUR CRITICAL SUPPORT
Jonna Gaberman, MD
& Bruce Wintman
Brian Galloway
Mark Gonthier
in memory of David Austin
Sharon Gray
Paul Groipen
Seth Grosshandler &
Kim Wainwright
Robert Haas
Roger Hanzes
Don Harpin
Mary Kay & Scott Herndon
Gavin Hilgemeier
William Hollis & John Kramer
Lawrence Hyer
Nick Jacovides
in honor of James P. Sartell
John J. Jakimczyk & Wendy Stead
Daniel Kasuba
Bennett Klein
Arnold Kraft
Richard & Susan Lampen
Timothy Leahy
Laurie Leibowitz
Tom Lewis
Rhonda Linde
in memory of David Huchinson
George Mair
Julie Marston
Sarah Marston
Wendy Marston
Michele Martin
Crane McCune
Dennis McAvoy & Bruce
Poduska
Ellen Morris McCann
& Peter McCann
CONTINUED FROM PAGE 6
Craig Radliff
in memory of Victor DePoalo Sr.
Neil Raymond & Amy LeVasseur
Gary Reinhardt
Michael Roberts
in honor of Jon Goode
& Cary Raymond
Lisa Pintchman Rogers
& Jay Rogers
in memory of Anne B. Morris
Nirka
Rosa
Sean McConnell
Larry
Rosenberg
William McDermott & Paul Reinert
Henry Rosenberg, MD &
George McGee
Katherine Hicks
John Morris Jr. & Sarah B. Holmes
in memory of Anne B. Morris
David Morris
Paul Ross, EdD
William Jacob Murray
Roger Sametz &
Ken Nimblett & Rusty Miller
DuncanRhys Liancourt
in honor of Craig Wells
Hannah & Jeffrey Olivet
Joe Orfant
Matthew Perlman
& William Hurlman
in memory of Dr. Ron Gelb
James Pierce & Rick Creswell
Theodore Pietras
Mildred Pintchman
in honor of Lisa Pintchman Rogers
Bernard Plovnick
Lenore Jackson Pope
Stephanie Qualls
in honor of Richard Durkin
Steven Schwartzberg, PhD
in honor of Craig Wells
Cynthia Shilkret, PhD
in memory of Anne B. Morris
David Silva
Richard Smith/Give with
Liberty Employee
Donation Program
John Spagnoletti
in memory of Mark Douville
Michael Stone, DMD
Peter Tenggren
Gerald Thorne
Steven Tromp
Elizabeth Warner
Donald Warren
Ann Webster, PhD
Leonard & Nancy Wells
Kathleen Whalen
Joel Zimet
Businesses, Organizations,
& Foundations
Abbvie
AmazonSmile
BNY Mellon Community
Partnership
Community Health Charities of
New England
Gilead Sciences
Harbor to the Bay
Janssen Biotech Inc.
Liberty Mutual Foundation
Match Program
Millennium Matching
Gift Program
Northstar Asset
Management, Inc.
Novartis U.S. Foundation
Sally Bowden Fund,
a Vanguard Charitable
donor-advised fund
in honor of Rob Curtis
State Street Foundation
A Special Way for You to Honor and Remember
Recognize Someone You Love with a Gift to CRI
Mildred Pintchman knows her daughter Lisa is amazing—she is talented,
giving, and accomplished. There are many ways for Mildred to show her
admiration, but each year, she makes a donation to CRI to recognize
Lisa’s special compassion for others. We thank Lisa, a longtime board
member, and her mother for sharing a commitment to clinical research
that changes lives.
You can honor or commemorate someone special in your life and help
advance CRI’s mission to lead the way in HIV and hepatitis C clinical
research. Your donation is a gift that gives health and hope every day.
When an In Honor or In Memory of gift is received, CRI will send
a personalized acknowledgement to the person or family indicated
notifying them of your thoughtful donation, but not revealing the
amount of the donation.
You can make a tribute gift online at:
http://crine.org/giving-options/donate-now/ or contact
Michael Corrente for more information at [email protected]
or 617.502.1710.
CRI ACCESS
7
You Make Lives Better—You Can Contribute to CRI in Many Ways
· DIRECT, UNRESTRICTED DONATIONS Place your gift in the general fund and support the day-to-day activities of
CRI. Your gifts of cash, stocks, or securities help CRI conduct research that makes lives better.
· MATCHING GIFTS You can maximize your gift if you (or a member of your family) qualify for corporate matching
funds. Please check with your company to see if they participate in a matching funds program, and include a matching
gift form to double the impact of your gift to CRI.
· GIFTS IN HONOR OR GIFTS IN MEMORY You can make a gift in honor of an individual, to celebrate a special
occasion, or in memory of a deceased friend or family member. CRI will notify whomever the donor designates.
· GIFTS OF BEQUESTS OR PLANNED GIVING CRI is grateful for your bequest gifts via wills and planned giving
arrangements. Please consider naming CRI as the beneficiary of your IRA, retirement fund, SEP, or insurance policy. We
encourage you to discuss your giving options with your lawyer or other financial representative to determine how you
can provide for the future growth of CRI while maximizing your tax benefits.
· GIFTS TO TEAM CRI THROUGH THE HARBOR TO THE BAY (H2B) HIV/AIDS BIKE RIDE You can support CRI’s H2B
efforts by riding or crewing with Team CRI, donating to your favorite Team CRI participant, or helping recruit sponsors.
Visit www.crine.org/h2b to learn more.
· GIFTS VIA CRI’S CARS PROGRAM If you have an old vehicle taking up space in your driveway or garage,
consider donating it to CRI—your 100% tax deductible donation goes straight to CRI’s critical HIV and hepatitis C
research efforts! Our CARS vehicle donation program manages all the logistics, so you don’t have to worry about
a thing.
A donation envelope is enclosed for your convenience.
For more information, please contact Michael Corrente at 617.502.1710 or [email protected].
DONATE ONLINE Just go to www.crine.org and click
DONATE
“I’ve witnessed firsthand what CRI does.
Being involved in numerous research studies
over the last 16 years has shown me their expertise,
dedication, and commitment. People are
alive because of CRI’s work, and to me that says it all!”
— Dr. Scott Sylvia, CRI Board of Directors President
Check out www.crine.org/our-research/clinical-trials
to learn more about CRI’s life-changing clinical trials!
our lifesaving research
our global impact
your critical support
o m m u n i t y
R
e s e a R C h
i
n i t i a t i v e
CRI
HDAP
38 Chauncy Street
Suite 500
Boston, MA 02111-2301
tel: 617.502.1700
fax administration: 617.502.1701
fax research: 617.502.1702
toll free: 888.253.2712
tel: 800.228.2714
fax: 617.502.1703
of new england
email: [email protected]
www.crine.org
DESIGN:
C